Magnetic particle imaging enables nonradioactive quantitative sentinel lymph node identification: feasibility proof...

Area of Science:

• Medical Imaging
• Oncology
• Nanotechnology

Background:

• Sentinel lymph node biopsy (SLNB) is crucial for cancer staging.
• Conventional methods using 99mTc radiotracers have limitations in half-life and resolution.
• Magnetic particle imaging (MPI) offers a nonradioactive alternative for image-guided SLNB.

Purpose of the Study:

• To demonstrate the sensitivity, specificity, and quantitative accuracy of MPI lymphography.
• To map sentinel lymph nodes (SLNs) in various lymphatic basins in murine models.
• To establish MPI as a viable tool for identifying SLNs.

Main Methods:

• Iron oxide nanoparticles were injected intradermally into mice.
• 3D MPI was used to detect nanoparticles in SLNs at multiple timepoints (1 hour to 4-6 days).
• Ex vivo analysis with Perl's Prussian iron staining confirmed MPI findings.

Main Results:

• MPI lymphography accurately identified SLNs in cervical, axillary, inguinal, and popliteal basins.
• MPI signals were detectable from 1 hour up to 4-6 days post-injection.
• Iron staining confirmed nanoparticle presence in the subcapsular space of excised SLNs.

Conclusions:

• MPI lymphography effectively detects SLNs using magnetic tracers for at least 4-6 days.
• This technique provides essential information for planning SLN approaches in cancer surgery.
• Clinical translation of MPI is supported by existing nanoparticle use in human imaging and recent regulatory approvals.